Laurus Labs Share Price Hits Fresh 52-Week High at Rs 2,050: Key Reasons Behind the Rally

Published: 24 September 2026 at 9:48 AM IST

Laurus Labs Share Price moved to Rs 2,043 today, up 0.4% from the previous close of Rs 2,034.8, and the stock touched a fresh 52-week high of Rs 2,050. The company’s market capitalisation stands at Rs 1,08,338 crore, placing this move in the context of a large listed healthcare name. For readers tracking Laurus Labs Share Price Today, the supplied data confirms the price event and the day’s range, but it does not establish a company-specific catalyst.

The stock opened at Rs 2,020.1, matched the day low at the same level, and reached Rs 2,050 during the session before settling near that peak. Laurus Labs Stock News therefore centres on a one-year high rather than a narrative about a disclosed trigger. In Univest coverage, this matters because Laurus Labs Share Price now sits at the top of its yearly range, while the next layer of analysis comes from fundamentals, sector valuation and peer comparison.

Laurus Labs Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 2,043
Previous Close	Rs 2,034.8
Today's Move	+Rs 8.2 (+0.4%)
Open	Rs 2,020.1
High	Rs 2,050
Low	Rs 2,020.1
Turnover	Rs 5.19 crore
Market Capitalisation	Rs 1,08,338 crore

Laurus Labs Ltd. (LAURUSLABS) traded at Rs 2,043 versus the previous close of Rs 2,034.8, a rise of 0.4%. The stock opened at Rs 2,020.1, reached a high of Rs 2,050 and touched a low of Rs 2,020.1.

Laurus Labs Share Price today shows a narrow upward move from Rs 2,034.8 to Rs 2,043, which is a gain of Rs 8.2 or 0.4%. The stock opened at Rs 2,020.1, stayed at that level as the day low, and rose to Rs 2,050, which is also the fresh 52-week high. That means the close was just Rs 7 below the session peak. The turnover was Rs 5.19 crore, a factual traded-value measure that helps quantify the day’s transaction value without implying any unverified trading story.

For Laurus Labs Share Price Today, the fresh 52-week high is the key event. The breakout from the earlier yearly peak can be measured directly from the supplied numbers: the previous 52-week high was Rs 2,050, so the current session matched that level rather than extending it. In simple share price news terms, Laurus Labs Share Price has moved into its yearly high zone and is now being watched through the lens of Laurus Labs Share News and broader market update coverage.

Laurus Labs Ltd. (LAURUSLABS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 1,08,338 crore
P/E Ratio	100.55x
P/B Ratio	19.5x
ROE	18.31%
ROCE	18.2%
EPS	Rs 20.24
Book Value Per Share	Rs 104.37
Dividend Yield	0.1%

Laurus Labs Ltd. (LAURUSLABS) fundamental metrics show P/E 100.55x, P/B 19.5x, ROE 18.31%, ROCE 18.2%. These figures provide context only and are not a buy or sell signal.

Laurus Labs Ltd. has a market capitalisation of Rs 108338 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 100.55x, P/B at 19.5x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.31% and ROCE of 18.2%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 20.24, book value per share of Rs 104.37, dividend yield of 0.1%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.89x, median ROE of 11.69%, median ROCE of 13.32%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	100.55x
Benchmark Median P/E	31.89x
Benchmark Average P/E	49.71x
Benchmark P/E Range	3.48x to 762.66x
Company P/B Ratio	19.5x
Benchmark Median P/B	2.95x
Company ROE	18.31%
Benchmark Median ROE	11.69%
Company ROCE	18.2%
Benchmark Median ROCE	13.32%
Company Market Capitalisation	Rs 1,08,338 crore
Benchmark Median Market Cap	Rs 745.38 crore

Laurus Labs Ltd. (LAURUSLABS) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Laurus Labs Ltd. (LAURUSLABS) has a P/E ratio of 100.55x, which is above the benchmark median of 31.89x, a difference of +215.3%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Laurus Labs Ltd. (LAURUSLABS) has a ROE of 18.31%, which is above the benchmark median of 11.69%, a difference of +56.63%. Laurus Labs Ltd. (LAURUSLABS) has a ROCE of 18.2%, which is above the benchmark median of 13.32%, a difference of +36.64%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Cipla Ltd.	CIPLA	1,11,565.25	33.08	3.17	11.83	16
Mankind Pharma Ltd.	MANKIND	1,02,410.4	49.79	6.04	12.69	13.24
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,15,810.19	25.85	4.33	19.69	21.39
Dr. Reddy's Laboratories Ltd.	DRREDDY	1,01,163.25	31.35	2.65	11.69	13.75
Aurobindo Pharma Ltd.	AUROPHARMA	97,641.63	26.73	2.55	9.93	12.76

Laurus Labs Ltd. (LAURUSLABS) has a P/E ratio of 100.55x compared with the displayed peer median of 31.35x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.31% compares with a peer median of 11.83% across the companies shown in the table. ROCE stood at 18.2% versus the displayed peer median of 13.75%, providing a capital-efficiency comparison. Laurus Labs Ltd. (LAURUSLABS) has a market capitalisation of Rs 1,08,338 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

Why Investors Are Watching Laurus Labs

• Laurus Labs Share Price touched a fresh 52-week high of Rs 2,050 during the session.
• Laurus Labs Share Price Today closed at Rs 2,043 after a Rs 8.2 rise from the previous close.
• The company’s market capitalisation stands at Rs 1,08,338 crore.
• P/E is 100.55 and P/B is 19.5, both above the industry benchmark in the supplied data.
• ROE is 18.31% and ROCE is 18.2%, both above the listed industry medians.

About Laurus Labs

Laurus Labs Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Laurus Labs Stock News and Laurus Labs Company News often focus on its listed identity, financial results and valuation context rather than on broad business claims. The company is traded on NSE and BSE, and the supplied data places Laurus Labs Share Price within a high-valuation healthcare peer set. Its reported EPS of Rs 20.24, book value of Rs 104.37 and dividend yield of 0.1% provide additional reference points for Laurus Labs Stock Analysis.

Track Laurus Labs Share Price on Univest

Use Laurus Labs Ltd. (LAURUSLABS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Track Laurus Labs Share Price on Univest for live share price updates, shareholding pattern, fundamental ratios, 52-week levels, market cap, peer comparison and company-specific market insights. Univest also presents Laurus Labs Share Price Today alongside key stock metrics in one place for quick review.

Frequently Asked Questions

Why did Laurus Labs Share Price hit a fresh 52-week high?

Ans. The supplied data confirms that Laurus Labs Share Price touched Rs 2,050, its fresh 52-week high, and closed at Rs 2,043. It does not establish a company-specific catalyst behind the move.

What is Laurus Labs Share Price today?

Ans. Laurus Labs Share Price today is Rs 2,043, up Rs 8.2 or 0.4% from the previous close of Rs 2,034.8. The session high was Rs 2,050 and the low was Rs 2,020.1.

What is the 52-week high for Laurus Labs Share Price?

Ans. The fresh 52-week high for Laurus Labs Share Price is Rs 2,050. The stock reached that level during the session and ended just below it at Rs 2,043. The stock moved 0.4% during the session.

What is the market cap of Laurus Labs?

Ans. Laurus Labs has a market capitalisation of Rs 1,08,338 crore. That figure is a company-size measure, and it helps place Laurus Labs Share Price within the healthcare sector context. The company operates in the Healthcare sector.

How does Laurus Labs compare with healthcare peers?

Ans. Laurus Labs has a higher P/E and P/B than the listed peer set in the supplied data, while its ROE is stronger than several peers. Its market cap is close to Cipla and Zydus Lifesciences.

What does Laurus Labs Fundamental Analysis show?

Ans. Laurus Labs Fundamental Analysis shows a P/E of 100.55, P/B of 19.5, ROE of 18.31%, ROCE of 18.2%, EPS of Rs 20.24 and book value of Rs 104.37. Dividend yield is 0.1%.

What is Laurus Labs Share Price news today?

Ans. Laurus Labs Share Price news today centres on the fresh 52-week high and the close at Rs 2,043. The data also shows turnover of Rs 5.19 crore and a market cap above Rs 1,08,000 crore.

Is Laurus Labs Stock News based on earnings data too?

Ans. Laurus Labs Stock News can also be read with the latest financial figures. Revenue rose to Rs 20,263.1 crore in Jun 2026, and net profit increased to Rs 3,676 crore in the same period.

What does Laurus Labs Share Price tell investors at this level?

Ans. Laurus Labs Share Price at Rs 2,043 shows a stock trading near its 52-week peak with valuation ratios above the industry medians. Investors can use Univest for continued tracking of company metrics and sector context.

Where can I track Laurus Labs Share Price live?

Ans. Laurus Labs Share Price can be tracked on Univest alongside market cap, shareholding pattern, valuation ratios and 52-week levels. The platform also keeps Laurus Labs Share Price Today in one place for quick monitoring.